Health Care Utilization by Body Mass Index in a Pediatric Population

Brian A Lynch1, Lila J Finney Rutten2, Robert M Jacobson3

  • 1Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minn.

Academic Pediatrics
|October 8, 2015
PubMed

Insights

Children with higher body mass index (BMI) categories, including overweight and obese, have more frequent emergency department (ED) and outpatient visits. However, increased BMI was not associated with higher hospitalization rates in this study.

Area of Science:

  • Pediatrics
  • Public Health
  • Epidemiology

Background:

  • Childhood obesity is a growing public health concern with potential implications for healthcare utilization.
  • Understanding the relationship between body mass index (BMI) categories and healthcare service use is crucial for resource allocation and preventive strategies.

Purpose of the Study:

  • To investigate whether children in higher body mass index (BMI) categories experience increased emergency department (ED) visits, outpatient clinic visits, and hospitalizations.
  • To control for demographic, socioeconomic, and other chronic medical conditions in the analysis.

Main Methods:

  • A cohort of 19,528 children aged 2-18 years from Olmsted County, Minnesota, with baseline BMI data was analyzed.
  • BMI was categorized into underweight/healthy weight (<85th percentile), overweight (85th to <95th percentile), and obese (≥95th percentile).
  • Negative binomial and multivariable regression models were used to compare healthcare utilization rates across BMI categories, adjusting for covariates.

Main Results:

  • Overweight and obese children showed significantly higher rates of ED visits compared to underweight/healthy weight children (IRR 1.16 and 1.27, respectively).
  • Increased outpatient clinic visits were also associated with overweight and obese status (IRR 1.05 and 1.07, respectively).
  • No significant association was found between baseline BMI category and hospitalization rates after adjustment.

Conclusions:

  • Overweight and obese children utilize emergency and outpatient services more frequently than their normal-weight peers.
  • Higher BMI in children is linked to increased non-hospitalization healthcare visits but not increased hospitalizations.
  • These findings highlight the impact of weight status on ambulatory care patterns in pediatric populations.
Abstract

Related Concept Videos

Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
341
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
783
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
467
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
386
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.5K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
333